Human dignity: a guide to policy making in the biotechnology era?
This article explores the ways in which human dignity is used in debates about controversial biotechnologies, including biobanks, human gene patents, stem cell research and human cloning. Increasingly, human dignity is used as a form of general condemnation and as blanket justification for regulatory restraint. However, this use of human dignity marks a significant departure from the traditional, human-rights informed view of human dignity that has dominated bioethics debates for decades. In addition, on its own, it stands as dubious justification for policies that are aimed at constraining controversial biotechnologies.
Caulfield
Timothy
T
Faculty of Law, University of Alberta, Edmonton, Alberta T6G 2H5, Canada. tcaulfld@law.ualberta.ca
Brownsword
Roger
R
D026688:Bioethical Issues; D001675:Bioethics; D001709:Biotechnology / Q000941:ethics* / Q000331:legislation & jurisprudence*; D019976:Cloning, Organism; D005821:Genetic Techniques; D006806:Human Rights; D006801:Humans; D007258:Informed Consent; D038622:Internationality; D010330:Patents as Topic; D011050:Policy Making; D011640:Public Policy